A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : DM2

Search Conditions:
Search Keyword : DM2
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: DM2
Appearance Frequency: 299 time(s)
Long forms: 50

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
diabetes mellitus type 2
(211 times)
Medicine
(47 times)
CVD (19 times)
BMI (14 times)
IR (7 times)
1999 Potential interactions of zinc in the neuroendocrine-endocrine disturbances of diabetes mellitus type 2.
DM type 2
(10 times)
Neurology
(5 times)
DM (8 times)
DM1 (5 times)
AGA (1 time)
2005 Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.
myotonic dystrophy type 2
(10 times)
Neurology
(5 times)
FXTAS (2 times)
SCA8 (2 times)
HDL2 (1 time)
2002 Dominantly inherited, non-coding microsatellite expansion disorders.
diabetes mellitus 2
(7 times)
Medicine
(2 times)
AF (1 time)
ANOVA (1 time)
BMI (1 time)
2003 Cardiovascular risk factors in the Lublin Region population with and without type-2 diabetes mellitus.
disorders in myotonic dystrophy type 2
(5 times)
Neurology
(4 times)
DM1 (3 times)
EDS (3 times)
RLS (2 times)
2004 Myotonic dystrophy: RNA pathogenesis comes into focus.
development and in myotonic dystrophy type 2
(3 times)
Biochemistry
(2 times)
sIBM (3 times)
CNBP (2 times)
CD (1 time)
2010 CNBP: a multifunctional nucleic acid chaperone involved in cell death and proliferation control.
diagnosed with myotonic dystrophy type 2
(3 times)
Molecular Biology
(1 time)
TP-PCR (1 time)
2010 Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2).
DMPK, while myotonic dystrophy type 2
(3 times)
Biophysics
(1 time)
DM (3 times)
2013 Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
decreased in erythrocytes of humans with type 2 diabetes
(2 times)
Biology
(1 time)
DMPC (1 time)
NO (1 time)
PDE3 (1 time)
2006 Expression of the heterotrimeric G protein Gi and ATP release are impaired in erythrocytes of humans with diabetes mellitus.
10  development of type 2 diabetes
(2 times)
Medicine
(1 time)
AD (1 time)
DMN (1 time)
FMD (1 time)
2005 Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.
11  disease called myotonic dystrophy type 2
(2 times)
Biochemistry
(1 time)
FECD (1 time)
IR (1 time)
NMR (1 time)
2011 The origin of genetic instability in CCTG repeats.
12  dyslipidaemia and type 2 diabetes
(2 times)
Urology
(1 time)
CV (1 time)
FGF21 (1 time)
WC (1 time)
2012 Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms.
13  dystrophy locus, myotonic dystrophy type 2
(2 times)
Genetics, Medical
(1 time)
DM (1 time)
DMPK (1 time)
PDM (1 time)
1998 Genetic mapping of a second myotonic dystrophy locus.
14  2-diabetes mellitus
(1 time)
Medicine
(1 time)
MDA (1 time)
2000 [Plasma malondialdehyde in patients with type 2 diabetes mellitus and in patients with coronary disease].
15  D virus M2 protein
(1 time)
Medicine
(1 time)
CM2 (1 time)
TEVC (1 time)
2018 Influenza D virus M2 protein exhibits ion channel activity in Xenopus laevis oocytes.
16  daily arterial stiffness parameters in patients with type 2 diabetes
(1 time)
Neurology
(1 time)
AAI (1 time)
CAN (1 time)
LC (1 time)
2015 [The effect of long-chain polyunsaturated omega-3 fatty acids on the arterial stiffness parameters in patients with diabetes mellitus type 2 and cardiovascular autonomic neuropathy].
17  damage Type 2 Diabetes
(1 time)
--- 2016 Confronting Complacency in the Face of Calamity: Mobilizing for the Home Front War against Diabetes.
18  DANGEROUS MIX2
(1 time)
Biology
(1 time)
NLR (1 time)
TIR (1 time)
2017 Activation of a Plant NLR Complex through Heteromeric Association with an Autoimmune Risk Variant of Another NLR.
19  data for myotonic dystrophy type 2
(1 time)
Neurology
(1 time)
BMC (1 time)
DEXA (1 time)
DM1 (1 time)
2019 Body composition analysis in patients with myotonic dystrophy types 1 and 2.
20  Data manager 2
(1 time)
Biochemistry
(1 time)
AMR (1 time)
TAT (1 time)
WTE (1 time)
2018 Designing and evaluating autoverification rules for thyroid function profiles and sex hormone tests.
21  define remission of type 2 diabetes
(1 time)
ADA (1 time)
2017 Variations in diabetes remission rates after bariatric surgery in Spanish adults according to the use of different diagnostic criteria for diabetes.
22  degree of control of the hypercholesterolaemia of type-2 diabetic
(1 time)
Primary Health Care
(1 time)
--- 2000 [Cost analysis and degree of hypercholesterolemia control in type 2 diabetic patients according to different groups and scientific societies].
23  demonstrate, using type 2 diabetes
(1 time)
Medicine
(1 time)
--- 2010 MicroRNA-integrated and network-embedded gene selection with diffusion distance.
24  Depression is a common complication in type 2 diabetes
(1 time)
Psychiatry
(1 time)
DIF (1 time)
EDS (1 time)
2011 Dimensionality and scale properties of the Edinburgh Depression Scale (EDS) in patients with type 2 diabetes mellitus: the DiaDDzoB study.
25  Depression is common in patients with diabetes type 2
(1 time)
Primary Health Care
(1 time)
CHD (1 time)
PHQ-9 (1 time)
Step-Dep (1 time)
2017 Process evaluation of a stepped-care program to prevent depression in primary care: patients' and practice nurses' experiences.
26  depression is common in patients with type 2 diabetes
(1 time)
Primary Health Care
(1 time)
CHD (1 time)
PNs (1 time)
2018 Patients' and practice nurses' perceptions of depression in patients with type 2diabetes and/or coronary heart disease screened for subthreshold depression.
27  determine the association of metabolic diseases, particularly diabetes type 2
(1 time)
Neoplasms
(1 time)
HT (1 time)
HUSM (1 time)
2008 Association of colorectal carcinoma with metabolic diseases; experience with 138 cases from Kelantan, Malaysia.
28  determine the effects of Type 2 diabetes
(1 time)
Neurology
(1 time)
--- 2017 Cognitive deficits in non-demented diabetic elderly appear independent of brain amyloidosis.
29  determine whether the management of type 2 diabetes
(1 time)
Internal Medicine
(1 time)
NSD (1 time)
2009 Diabetes specialist nurse as main care provider for patients with type 2 diabetes.
30  development of cardiovascular dysfunction in type 2 diabetes
(1 time)
Medicine
(1 time)
--- 2013 Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies.
31  development of foot ulcers in patients with type 2 diabetes
(1 time)
Medicine
(1 time)
DMD (1 time)
2009 [Foot ulceration risk factors in type 2 diabetes mellitus].
32  diabetes mellitus of 2nd type
(1 time)
Medicine
(1 time)
CHD (1 time)
NAFLD (1 time)
2013 [Additional advantages of mexicor used in combined therapy of coronary heat disease and diabetes mellitus of 2nd type].
33  diabetes mellitus of type 2
(1 time)
Medicine
(1 time)
IHD (1 time)
MAP (1 time)
2004 [Diagnostics of microcirculatory disorders in patients with diabetes mellitus type 2 and ischemic heart disease].
34  diets in the primary-care management of type 2 diabetic
(1 time)
Diabetes Mellitus
(1 time)
KD (1 time)
2019 Optimizing glycemic control in type 2 diabetic patients through the use of a low-carbohydrate, high-fat, ketogenic diet: a review of two patients in primary care.
35  discovered gene locus of myotonic dystrophy type 2
(1 time)
Neurology
(1 time)
PROMM (1 time)
1999 Linkage of proximal myotonic myopathy to chromosome 3q.
36  discrimination on the continuity of Type 2 Diabetes
(1 time)
Medicine
(1 time)
--- 2016 [Healthcare mistreatment attributed to discrimination among mapuche patients and discontinuation of diabetes care].
37  disease'; and (2) myotonic dystrophy type 2
(1 time)
Neurology
(1 time)
DM1 (1 time)
2010 The myotonic dystrophies: diagnosis and management.
38  diseased controls with myotonic dystrophy type 2
(1 time)
ALS (1 time)
BPI (1 time)
2015 Characteristics of pain in amyotrophic lateral sclerosis.
39  Disturbed glucose metabolism, particularly in diabetes type 2
(1 time)
Geriatrics
(1 time)
AGE (1 time)
CM (1 time)
LF (1 time)
2013 Advanced glycation end products and lipofuscin deposits share the same location in cardiocytes of the failing heart.
40  DM of type 2
(1 time)
Medicine
(1 time)
DM (1 time)
DM1 (1 time)
2008 Repeat length and RNA expression level are not primary determinants in CUG expansion toxicity in Drosophila models.
41  DM type 2 model
(1 time)
Cell Biology
(1 time)
DM (1 time)
PTCs (1 time)
TEM (1 time)
2018 Reabsorption in the proximal tubuli-ultrastructural evidence for a novel aspect of renal VEGF trafficking.
42  DM1 and myotonic dystrophy type 2
(1 time)
Molecular Biology
(1 time)
CUGBP1 (1 time)
MBNL1 (1 time)
NCAM (1 time)
2010 Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
43  DM2 group
(1 time)
Andrology
(1 time)
BE2 (1 time)
BT (1 time)
CG (1 time)
2014 Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus.
44  DM2-LDL
(1 time)
Endocrinology
(1 time)
Ang II (1 time)
IGT-LDL (1 time)
LDL (1 time)
2009 Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion.
45  Drosophila model of myotonic dystrophy type 2
(1 time)
Medicine
(1 time)
CELF1 (1 time)
2017 (CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis.
46  dyslipidemia is particularly common in people with type 2 diabetes
(1 time)
Ophthalmology
(1 time)
DR (1 time)
P/L (1 time)
PDW (1 time)
2016 The association of hematologic inflammatory markers with atherogenic index in type 2 diabetic retinopathy patients.
47  dystrophia myotonica type 2
(1 time)
Genetics, Medical
(1 time)
DM (1 time)
DM1 (1 time)
2004 Insulin receptor splicing alteration in myotonic dystrophy type 2.
48  dystrophies in adulthood; however, myotonic dystrophy type 2
(1 time)
Neurology
(1 time)
NMDs (1 time)
PROs (1 time)
2018 Towards clinical outcome measures in myotonic dystrophy type 2: a systematic review.
49  dystrophy: higher than expected frequency of myotonic dystrophy type 2
(1 time)
Genetics, Medical
(1 time)
DM (1 time)
NMD (1 time)
2011 Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
50  type-2-diabetes mellitus
(1 time)
Biochemistry
(1 time)
--- 2012 Relationship of fetuin-A levels to weight-dependent insulin resistance and type 2 diabetes mellitus.